Sharps Technology, Inc. (STSS)
USD 4.75
(-9.35%)
USD 4.75
(-9.35%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -9.84 Million USD | -1361.93% |
| 2022 | 779.88 Thousand USD | 116.14% |
| 2021 | -4.83 Million USD | -105.83% |
| 2020 | -2.34 Million USD | -14.19% |
| 2019 | -2.05 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -982.38 Thousand USD | 68.33% |
| 2024 Q2 | -2.1 Million USD | -114.0% |
| 2023 Q4 | -3.1 Million USD | -53.37% |
| 2023 FY | -9.84 Million USD | -1361.93% |
| 2023 Q2 | -2.6 Million USD | -50.05% |
| 2023 Q3 | -2.02 Million USD | 22.39% |
| 2023 Q1 | -1.73 Million USD | -133.66% |
| 2022 Q4 | 5.15 Million USD | 272.04% |
| 2022 Q3 | -2.99 Million USD | -180.12% |
| 2022 Q2 | 3.74 Million USD | -100.0% |
| 2022 Q1 | 245.43 Billion USD | 15360596.3% |
| 2022 FY | 779.88 Thousand USD | 116.14% |
| 2021 Q1 | -914.68 Thousand USD | -7.55% |
| 2021 FY | -4.83 Million USD | -105.83% |
| 2021 Q3 | -1.34 Million USD | -65.45% |
| 2021 Q2 | -810.64 Thousand USD | 11.37% |
| 2021 Q4 | -1.59 Million USD | -19.13% |
| 2020 Q4 | -850.51 Thousand USD | -35.78% |
| 2020 Q3 | -626.38 Thousand USD | 0.0% |
| 2020 FY | -2.34 Million USD | -14.19% |
| 2019 FY | -2.05 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Akoya Biosciences, Inc. | -63.32 Million USD | 84.458% |
| AngioDynamics, Inc. | -184.34 Million USD | 94.661% |
| AtriCure, Inc. | -30.43 Million USD | 67.667% |
| Avinger, Inc. | -18.32 Million USD | 46.279% |
| Azenta, Inc. | -14.25 Million USD | 30.97% |
| BioLife Solutions, Inc. | -66.42 Million USD | 85.184% |
| The Cooper Companies, Inc. | 294.2 Million USD | 103.345% |
| Daxor Corporation | 280.64 Thousand USD | 3606.855% |
| Ekso Bionics Holdings, Inc. | -15.19 Million USD | 35.244% |
| Femasys Inc. | -14.24 Million USD | 30.922% |
| GlucoTrack, Inc. | -7.09 Million USD | -38.673% |
| Harvard Bioscience, Inc. | -3.41 Million USD | -188.189% |
| Hologic, Inc. | 789.5 Million USD | 101.247% |
| ICU Medical, Inc. | -29.65 Million USD | 66.813% |
| Intuitive Surgical, Inc. | 1.79 Billion USD | 100.547% |
| KORU Medical Systems, Inc. | -13.74 Million USD | 28.378% |
| LeMaitre Vascular, Inc. | 30.1 Million USD | 132.691% |
| Innovative Eyewear, Inc. | -6.66 Million USD | -47.696% |
| Innovative Eyewear, Inc. | -6.66 Million USD | -47.696% |
| Masimo Corporation | 81.5 Million USD | 112.076% |
| Microbot Medical Inc. | -10.74 Million USD | 8.365% |
| Meihua International Medical Technologies Co., Ltd. | 11.62 Million USD | 184.656% |
| Merit Medical Systems, Inc. | 94.41 Million USD | 110.424% |
| Nephros, Inc. | -1.57 Million USD | -524.866% |
| NovoCure Limited | -207.04 Million USD | 95.247% |
| NEXGEL, Inc. | -3.15 Million USD | -211.74% |
| NEXGEL, Inc. | -3.15 Million USD | -211.74% |
| Singular Genomics Systems, Inc. | -94.82 Million USD | 89.621% |
| OraSure Technologies, Inc. | 53.65 Million USD | 118.342% |
| Pro-Dex, Inc. | 2.12 Million USD | 562.7% |
| Pulse Biosciences, Inc. | -42.21 Million USD | 76.684% |
| Predictive Oncology Inc. | -13.98 Million USD | 29.622% |
| Precision Optics Corporation, Inc. | -2.95 Million USD | -233.459% |
| QuidelOrtho Corporation | -10.1 Million USD | 2.558% |
| Repligen Corporation | 41.57 Million USD | 123.671% |
| Sanara MedTech Inc. | -4.3 Million USD | -128.705% |
| STAAR Surgical Company | 21.34 Million USD | 146.103% |
| Utah Medical Products, Inc. | 16.63 Million USD | 159.162% |
| DENTSPLY SIRONA Inc. | -132 Million USD | 92.544% |
| Jin Medical International Ltd. | 2.87 Million USD | 441.934% |